Abstract:Depression is highly prevalent in individuals with diabetes and further increases the risk of the development of diabetes 1. Accumulating evidence shows that a diagnosis of type 2 diabetes could increase the risk of incident depression and aggravate a more severe course of depression 2. Recently, we read with great interest the article entitled ‘Antidepressant-like Effect of Insulin in Streptozotocin-induced Type 2 Diabetes Mellitus Rats' by Sestile et al. 3, in which the authors using streptozotocin (STZ)-induced type 2 diabetes mellitus rats demonstrated that daily treated for consecutive 21 days with insulin significantly decreased immobility time of forced swimming test (FST), indicating that insulin, a peptide hormone secreted by β cells in the pancreas, which is intended to treat diabetes by regulation of the metabolism of carbohydrates and fats via improving the consumption of glucose from the blood to skeletal muscles 4, has markedly antidepressant effect in diabetic rats. Although the authors of the study did not present any data to elucidate its potential mechanism, we would like to put forward a hypothesis in this letter that is highly relevant to this study. Increasing evidence shows depression is often comorbid with somatic symptoms such as chronic back pain, which are primarily due to the suppression of physiological functions of skeletal muscle 5. Interestingly, besides antidepressant and pain-relieving agents, regular exercises are commonly prescribed for depressed patients 6. It is well recognized that regular exercise may exert beneficial effects for the improvement of inactive skeletal muscle functions in depressed patients 7. Additionally, a previous rodent study suggests that animals after regular exercise by treadmill would significantly facilitate the therapeutic effects for depression 8. Furthermore, an excellent study by Agudelo et al. 9 demonstrates that activation of skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator 1α1 (PGC1α1), a critical metabolic coactivator, may strengthen the resilience to chronic stress. The authors of this study only observed the antidepressant effect in the STZ-induced diabetic animal model, but did not further investigate its effects by using conventional depressive animal models. Hence, we inferred that insulin may fail to elicit antidepressant actions in conventional depressive animal models as this model is not associated with disturbances of metabolism in skeletal muscle tissues. Collectively, these findings suggest that improvement of skeletal muscle may exert a beneficial effect for the alleviation of depression-associated symptoms. Currently, mounting studies indicate that the underlying mechanisms of antidepressant agents are mainly attributed to the regulation of abnormalities of monoamine transmitters in the synaptic cleft 10. A previous study performed by Gupta et al. 11 using STZ-induced diabetic animal model shows that insulin successfully exerts therapeutic effects for depression symptoms, which is potentially associated with the effective modulation of the brain serotonin system. Nevertheless, to the best of our knowledge, insulin's molecular is approximately 5808 Dalton, which could not be easily passed through the blood–brain barrier 12. Most importantly, insulin exerting pharmacological benefits is primarily located in skeletal muscles by up-regulating consumption of glucose 13. Although the exact mechanisms of insulin's specific effects for depressive symptoms have not been determined, a possible mechanism that enhancing skeletal muscle function by insulin may facilitate the treatment of depression cannot be ignored. In addition, the notion that deficits in monoamine reuptake system in the synaptic cleft underlie the pharmacological actions of antidepressant agents has generally been accepted by most neuroscientists and psychiatrists. This is not to be taken to mean, however, that all the agents possessing peculiar beneficial effects for depression are solely associated with the conventional notion of monoamine theory. In this regard, we infer that pharmacological benefits of insulin for treating depression are probably related with enhancing effects in skeletal muscle, rather than in the central nervous system. In conclusion, improving skeletal muscle may favour the treatment of depression. And moreover, insulin's pharmacological benefits for depression are probably associated with the up-regulation of inactive state of skeletal muscle induced by diabetes. Future studies are needed to further investigate the possible mechanisms of the comorbidity of depression and diabetes, and fully elucidate insulin's pharmacological property. This study was supported by the Program of Bureau of Science and Technology Foundation of Changzhou (No: CJ20159022) and Major Science and Technology Projects of Changzhou Municipal Committee of Health and Family Planning (No: ZD201505). The authors declared no any potential conflicts of interest.

Insulin alleviates degradation of skeletal muscle protein by inhibiting the ubiquitin-proteasome system in septic rats

Regulation effect of insulin on the hypermetabolism of the skeletal muscles of septic patients through ubiquitin-proteasome pathway

Insulin Ameliorating Endotoxaemia-Induced Muscle Wasting is Associated with the Alteration of Hypothalamic Neuropeptides and Inflammation in Rats.

Role Of Ampk Alpha In Skeletal Muscle Glycometabolism Regulation And Adaptation In Relation To Sepsis

[Effects of Insulin Receptor Substrate-1 and Its Serine Phosphorylation and Tyrosine Phosphorylation on Insulin Resistance in Skeletal Muscle Cells in the State of Sepsis: Experiment with Rats].

Insulin alleviates the inflammatory response and oxidative stress injury in cerebral tissues in septic rats

Local insulin-like growth factor I prevents sepsis-induced muscle atrophy

Effects of insulin receptor substrate-1 and its serine phosphorylation and tyrosine phosphorylation on insulin resistance in skeletal muscle of sepsis: Experiment with rats

Exercise preconditioning attenuates atrophic mediators and preserves muscle mass in acute sepsis.

Hypothalamic AMPK-induced Autophagy Ameliorates Hypercatabolism in Septic Rats by Regulating POMC Expression

Mild Hypothermia Ameliorates Muscle Wasting in Septic Rats Associated with Hypothalamic AMPK-induced Autophagy and Neuropeptides.

Insulin Restores UCP3 Activity and Decreases Energy Surfeit to Alleviate Lipotoxicity in Skeletal Muscle.

[Nuclear Factor Kappa B Impairs Insulin Signaling Pathway in Skeletal Muscle Cells of Rat with Sepsis].

Experimental Study of Changes in Protein Metabolism of Skeletal Muscle in Sepsis

CELLULAR SENESCENCE IMPLICATED IN SEPSIS-INDUCED MUSCLE WEAKNESS AND AMELIORATED WITH METFORMIN

Estrogen Maintains Skeletal Muscle in Septic Rats Associated with Altering Hypothalamic Inflammation and Neuropeptides

Parkin Overexpression Attenuates Sepsis-Induced Muscle Wasting

Insulin sensitivity of muscle protein metabolism is altered in patients with chronic kidney disease and metabolic acidosis

High-intensity exercise alongside insulin alleviates muscle atrophy in type 1 diabetes mellitus concomitant with modulation of mitophagy-related proteins in skeletal muscle

A Potential Mechanism Underlying the Antidepressant Effect of Insulin

Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice.